Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-19-020706
Filing Date
2019-10-21
Accepted
2019-10-21 16:07:46
Documents
1
Period of Report
2019-10-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 11946
  Complete submission text file 0001213900-19-020706.txt   13343
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

IRS No.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 EAST 56TH STREET, APT 19E NEW YORK, NY 10022
Business Address
Kelly Paul Edward (Reporting) CIK: 0001658544 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39082 | Film No.: 191159688